HIV-1 and HIV-2 prevalence, risk factors and birth outcomes among pregnant women in Bissau, Guinea-Bissau: a retrospective cross-sectional hospital study.

Scientific Reports
Dlama Nggida RasmussenHolger Werner Unger

Abstract

The human immunodeficiency virus (HIV) remains a leading cause of maternal morbidity and mortality in Sub-Saharan Africa. Prevention of mother-to-child transmission (PMTCT) has proven an effective strategy to end paediatric infections and ensure HIV-infected mothers access treatment. Based on cross-sectional data collected from June 2008 to May 2013, we assessed changes in HIV prevalence, risk factors for HIV, provision of PMTCT antiretroviral treatment (ART), and the association between HIV infection, birth outcomes and maternal characteristics at the Simão Mendes National Hospital, Guinea-Bissau's largest maternity ward. Among 24,107 women, the HIV prevalence was 3.3% for HIV-1, 0.8% for HIV-2 and 0.9% for HIV-1/2. A significant decline in HIV-1, HIV-2, and HIV-1/2 prevalence was observed over time. HIV infection was associated with age and ethnicity. A total of 85% of HIV-infected women received ART as part of PMTCT, yet overall treatment coverage during labour and delivery declined significantly for both mothers and infants. Twenty-two percent of infants did not receive treatment, and 67% of HIV-2-infected mothers and 77% of their infants received ineffective non-nucleoside reverse transcriptase inhibitors for PMTCT. Matern...Continue Reading

References

Mar 7, 2000·JAMA : the Journal of the American Medical Association·K M De CockN Shaffer
Jan 5, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·J L ColeyW W Fawzi
Oct 21, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Carla van TienenHilton Whittle
Sep 14, 2010·The Journal of Infection·Erika GianelliMassimo Galli
Apr 19, 2011·Lancet·Joy E LawnUNKNOWN Lancet's Stillbirths Series steering committee
Aug 29, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Bo Langhoff HøngeUNKNOWN Bissau HIV Cohort Study Group
Nov 22, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Bo Langhoff HøngeUNKNOWN Bissau HIV Cohort Study Group
Jan 2, 2015·Bulletin of the World Health Organization·Sanne JespersenUNKNOWN Bissau HIV cohort study group
Apr 19, 2015·Virology Journal·Sanne JespersenUNKNOWN Bissau HIV cohort study group
Aug 25, 2015·Journal of the International Association of Providers of AIDS Care·Charlotte DyrehaveUNKNOWN Bissau HIV Cohort Study Group
Oct 2, 2015·Journal of the International AIDS Society·Sanne JespersenUNKNOWN Bissau HIV Cohort study group
Oct 21, 2015·AIDS·Helen R FryerThushan I de Silva
Jan 15, 2016·The Lancet. HIV·Chrystelle O O WediJoris Hemelaar
Apr 7, 2016·The Lancet Infectious Diseases·Ceri EvansAndrew J Prendergast
Jul 19, 2016·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Aug 8, 2017·JAMA Pediatrics·Rebecca ZashRoger L Shapiro
May 24, 2018·PloS One·Morten Bjerregaard-AndersenChristine Stabell Benn
May 31, 2018·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jessica Londeree SaleskaJesse J Kwiek
Jul 1, 2018·The Lancet. HIV·Heather BaileyClaire Thorne
Jul 26, 2018·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sanne JespersenUNKNOWN Bissau HIV Cohort study group
Jul 28, 2018·Lancet·Jade GhosnChristine Katlama
Aug 14, 2018·Tropical Medicine & International Health : TM & IH·Ditte SteinicheUNKNOWN Bissau HIV Cohort Study Group
Feb 6, 2020·AIDS Research and Therapy·S JespersenB L Hønge

❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.